According to MarketsandMarkets™, the Next-Generation Sequencing Market is projected to grow from about USD 14.94 billion in ...
According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...
A recent study on the application of Metagenomic next-generation sequencing (mNGS) found that mNGS can achieve early detection of pathogens and accelerate the development of targeted anti-infection ...
Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...
Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...
According to MarketsandMarkets, the Next-Generation Sequencing Market is projected to grow from about USD 14.94 billion in 2025 to USD 29.53 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback